Description
RETATRUTIDE 30MG
30mg | Laboratory Research Grade
Strictly for Research Purposes – Not for Human Consumption
Retatrutide is an experimental peptide within the incretin class, acting as a triple agonist of the GLP-1, GIP, and GCGR receptors. This high-purity Retatrutide 30mg format is specifically developed for advanced research protocols focusing on long-term metabolic study and hormonal synergistic impacts.
Product Technical Specifications
| Feature | Specification |
|---|---|
| Compound | Retatrutide |
| Sequence | Tyr-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-α-Me-Leu-Leu-Asp-Lys-diacid-C20-γ-Glu-(AEEA)-Lys-Ala-Gln-Aib-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 |
| Molecular Weight | 4731.33 g/mol |
| Analytical Purity | > 98% (HPLC Certified) |
| Quantity | 30 mg per vial |
| Grade | Laboratory Research Grade |
Retatrutide 30mg Research Application Areas
Scientific investigations on Retatrutide 30mg focus on the following core research areas:
- Triple Hormonal Agonism: Simultaneous GLP-1, GIP, and Glucagon receptor activation.
- Enhanced Energy Expenditure: Basal metabolic rate research via GCGR pathways.
- Lipid Metabolism: Study of hepatic steatosis reduction in high-concentration models.
- Satiety Mechanisms: Impact on central caloric intake regulation.
Looking for another similar research compound alternative? Explore our full range of Research Peptides.
⚠️ MANDATORY LEGAL DISCLAIMER: THIS PRODUCT IS NOT INTENDED FOR HUMAN CONSUMPTION. IT IS SOLD EXCLUSIVELY FOR LABORATORY USE AND RESEARCH PURPOSES.
